Chris Britten

Chris Britten has extensive experience in business development and mergers and acquisitions within the pharmaceutical industry. Chris has held high-level positions such as Senior Vice President at Grünenthal Group and Senior Vice President at ADVANZ PHARMA, among others. In addition, they have served as Managing Director at Vantage Life Science Consulting and as a Non-Executive Director at N4 Pharma Plc and Phico Therapeutics Ltd.

Chris Britten completed a Bachelor of Science (Hons) degree in Biology at the University of York from 1985 to 1988. Chris then pursued a PhD in Biochemistry at the same institution from 1988 to 1992. Finally, they obtained an MBA with a focus on Finance, Entrepreneurship, and Strategy from the London Business School from 1999 to 2001.